The impact of Aurora kinase A genetic polymorphisms on cervical cancer progression and clinicopathologic characteristics.

Abstract

The aims of this study were to explore the involvement of Aurora kinase A (AURKA) gene single nucleotide polymorphisms (SNPs) in uterine cervical cancer that has not yet been investigated. One hundred and six patients with cervical invasive cancer and 94 patients with precancerous lesions, and 302 Taiwanese female individuals were included. AURKA SNPs rs2273535, rs6024836, rs2064863 and rs1047972 were analyzed for genotypic distributions using real-time polymerase chain reaction. There were no statistically significant differences in the genetic frequencies of AURKA SNPs among patients with invasive cancer and those with precancerous lesions of uterine cervix and control women. There were no associations among AURKA SNPs and clinicopathologcal variables and recurrence and survival events. However, in a multivariate analysis, cervical cancer patients with adenocarcinoma (HR: 3.18, 95% CI: 1.23-8.23; p=0.017) and larger tumor (HR: 5.61, 95% CI: 2.10-14.95; p=0.001) had poorer recurrence-free survival. In conclusion, tumor size and pelvic lymph node status rather than AURKA SNPs were the most obvious independent parameter that could significantly predict 5 years survival rate in Taiwanese women with cervical cancer.

• Authors: Pei-Ju Wu, Chun-Hao Wang, Ming-Hong Hsieh, Chung-Yuan Lee, Po-Hui Wang, Chiao-Wen Lin, Shun-Fa Yang, Maw-Sheng Lee
• Journal: International journal of medical sciences (Int J Med Sci) Vol. 18 Issue 11 Pg. 2457-2465 ( 2021) ISSN: 1449-1907 [Electronic] Australia
• PMID: 33967624 (Publication Type: Journal Article, Observational Study)
• Copyright: © The author(s).

Chemical References

• AURKA protein, human
• Aurora Kinase A

Topics

• Adenocarcinoma (diagnosis, genetics, mortality, therapy)
• Adult
• Age Distribution
• Aged
• Aurora Kinase A (genetics)
• Cervix Uteri (pathology)
• Disease Progression
• Disease-Free Survival
• Female
• Humans
• Middle Aged
• Neoplasm Recurrence, Local (epidemiology, genetics)
• Neoplasm Staging
• Polymorphism, Single Nucleotide
• Survival Rate
• Taiwan (epidemiology)
• Uterine Cervical Neoplasms (diagnosis, genetics, mortality, therapy)
• Uterine Cervical Dysplasia (diagnosis, genetics, mortality, therapy)